DEVELOPMENT OF AMIDINES AS SELECTIVE MUSCARINIC AGONISTS

脒作为选择性毒蕈碱激动剂的开发

• 批准号: 6258840
• 负责人: WILLIAM S MESSER
• 金额: $ 0.01万
• 依托单位: MICHIGAN STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-06-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6258840
• 关键词: bacteria; biological products; biomedical resource; carbohydrates; growth factor; technology /technique development

Research in our laboratory focuses on the development of novel muscarinic agonists for the treatment of neurological disorders, including Alzheimers disease and chronic pain. Characterization of new compounds requires mass spectral data analysis, and our laboratory depends heavily on the MSU Facility for help with structure determination and verification.

我们实验室的研究主要集中在小说的开发上 用于治疗神经疾病的毒鼠碱激动剂， 包括阿尔茨海默病和慢性疼痛。特征描述 新化合物需要进行质谱分析，而我们的实验室 在很大程度上依赖密歇根州立大学的设施来帮助构建 确定和核实。